3D Medicines (Sichuan) Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   KN035 for dMMR/MSI-H Advanced Solid Tumors

   Enrollment closed, study ongoing

   Also in this update: Trial sites expanded: 1 → 27 locations

   3D Medicines (Sichuan) Co., Ltd.·Phase 2· NCT03667170· Registry history of NCT03667170 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

2. Minor

   KN035-BTC · Programmed Death Ligand (PD-L1) Combined With…KN035-BTC · Programmed Death Ligand (PD-L1) Combined With Chemotherapy · BTC

   Trial completed

   Also in this update: Study completion date changed from estimate of Dec 31, 2026 to Sep 10, 2024

   3D Medicines (Sichuan) Co., Ltd.·Phase 3· NCT03478488· Registry history of NCT03478488 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.